LENSAR, Inc. (NASDAQ:LNSR) Short Interest Up 92.9% in April

LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 208,700 shares, a growth of 92.9% from the March 31st total of 108,200 shares. Based on an average daily trading volume, of 174,500 shares, the days-to-cover ratio is presently 1.2 days. Approximately 2.3% of the company's shares are sold short.

LENSAR Stock Up 0.9 %

LENSAR stock opened at $14.03 on Tuesday. LENSAR has a 52 week low of $2.95 and a 52 week high of $17.31. The firm's 50-day simple moving average is $13.62 and its 200 day simple moving average is $9.98. The firm has a market capitalization of $165.40 million, a PE ratio of -9.61 and a beta of 0.56.

LENSAR (NASDAQ:LNSR - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported ($1.61) EPS for the quarter, missing the consensus estimate of ($0.21) by ($1.40). The business had revenue of $16.73 million during the quarter, compared to analysts' expectations of $14.95 million. LENSAR had a negative return on equity of 49.02% and a negative net margin of 34.03%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Renaissance Technologies LLC increased its stake in shares of LENSAR by 13.3% during the 4th quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock valued at $3,119,000 after acquiring an additional 40,946 shares during the last quarter. Geode Capital Management LLC increased its position in shares of LENSAR by 5.6% in the fourth quarter. Geode Capital Management LLC now owns 106,058 shares of the company's stock worth $948,000 after acquiring an additional 5,627 shares in the last quarter. Brandes Investment Partners LP raised its stake in shares of LENSAR by 10.4% in the 4th quarter. Brandes Investment Partners LP now owns 489,318 shares of the company's stock valued at $4,375,000 after acquiring an additional 45,920 shares during the period. Essex Investment Management Co. LLC lifted its holdings in shares of LENSAR by 18.3% during the 4th quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock valued at $357,000 after acquiring an additional 6,184 shares in the last quarter. Finally, Atria Investments Inc lifted its holdings in shares of LENSAR by 28.2% during the 4th quarter. Atria Investments Inc now owns 26,055 shares of the company's stock valued at $233,000 after acquiring an additional 5,729 shares in the last quarter. Institutional investors and hedge funds own 40.15% of the company's stock.

Analyst Upgrades and Downgrades

LNSR has been the subject of several analyst reports. Lake Street Capital reaffirmed a "hold" rating and set a $15.00 price objective (down from $16.00) on shares of LENSAR in a research report on Monday, March 24th. BTIG Research lowered LENSAR from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 24th.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.